A new review in the Journal of Pharmaceutical Investigation presents lipid excipients as far more than passive ingredients used to fill capsules or improve tablet manufacture. Drawing on pharmaceutical considerations from Gattefossé’s lipid portfolio, the article describes how carefully selected lipids can influence a medicine’s solubility, stability, gastrointestinal behavior, absorption, release profile and patient acceptability. The authors, K. Yoon, P. Caisse, H. Ouyang and colleagues, argue that lipid-based formulation strategies are becoming increasingly important as drug discovery produces more compounds with poor water solubility. These molecules may show strong biological activity in laboratory testing but fail to reach effective concentrations in the body because they dissolve poorly in gastrointestinal fluids.
Lipid excipients address this challenge through several complementary mechanisms. Their chemical structures allow them to interact with hydrophobic drug molecules, creating formulations in which the active ingredient is dissolved, dispersed or held in a finely organized colloidal system. Depending on the material, a lipid may function as a solvent, surfactant, co-surfactant, emulsifier, binder, coating agent or release modifier. This multifunctionality gives formulation scientists more control than conventional water-soluble excipients alone can provide. The review emphasizes that the choice of lipid is not simply a matter of selecting an ingredient with a suitable melting point or viscosity. Its fatty-acid composition, hydrophilic–lipophilic balance, digestion behavior, compatibility and processing characteristics can all determine whether a dosage form succeeds.
One of the most important applications is the development of lipid-based formulations for poorly soluble drugs. In self-emulsifying drug delivery systems, a mixture of oils and surfactants spontaneously forms an emulsion or fine dispersion when it encounters gastrointestinal fluid. The resulting droplets provide a large interfacial area, helping maintain the drug in a solubilized state and improving contact with the intestinal surface. Smaller droplets can support more efficient dispersion, although excessive surfactant concentrations may irritate the gastrointestinal tract or create manufacturing and stability problems. The review therefore presents formulation design as a balance between solubilization capacity, tolerability, physical stability and the amount of excipient required.
The digestive fate of a lipid formulation is equally important. After oral administration, dietary and formulation lipids are exposed to bile salts, phospholipids and pancreatic enzymes. Triglycerides may be hydrolyzed into fatty acids and monoglycerides, which can combine with bile components to form mixed micelles and other colloidal structures. These structures can keep hydrophobic drug molecules dispersed in the intestinal environment and transport them toward the absorptive membrane. For selected compounds, lipid digestion may also promote access to the lymphatic system, potentially reducing the extent of first-pass metabolism in the liver. However, these effects depend on the drug’s physicochemical properties, the formulation composition and the individual’s digestive state.
The article also highlights the role of lipid excipients in solid oral dosage forms, where their behavior can be used to engineer drug release. High-melting lipids may create matrices or coatings that slow the penetration of gastrointestinal fluids and delay drug diffusion. Other lipid materials can act as binders or plasticizers, improving the mechanical properties of granules, pellets and tablets. In multiparticulate systems, lipid coatings can provide more uniform release across many small units, potentially reducing the risk of dose dumping associated with a single large tablet. Materials such as glycerides, fatty acids and wax-like excipients may therefore contribute to immediate-release, sustained-release or delayed-release designs, depending on their composition and processing history.
Lipid systems can also help solve practical problems that appear during manufacturing. Some active pharmaceutical ingredients crystallize during storage, separate from their carrier or become difficult to compress into tablets. Lipid excipients can improve wetting and dispersion, reduce dust formation and support processes such as hot-melt coating or melt granulation. Their thermoplastic properties allow certain formulations to be processed without conventional solvents, an advantage for manufacturing efficiency and environmental considerations. At the same time, heat-sensitive drugs may require careful control of processing temperature, and the solid-state behavior of the lipid must be monitored because changes in polymorphism can alter hardness, dissolution and drug release over time.
Another area of interest is the use of lipid excipients to improve the patient experience. Poor taste, unpleasant mouthfeel and difficulty swallowing can reduce adherence, particularly in pediatric, geriatric and chronic-care populations. Lipid-based coatings and matrices may help mask bitterness or reduce direct contact between the active ingredient and taste receptors. They can also support the production of soft capsules, chewable systems and other dosage forms designed for easier administration. These benefits are not merely cosmetic: improved palatability can influence whether a patient takes a medicine consistently enough to achieve therapeutic benefit.
The review stresses that successful lipid formulation requires a detailed understanding of the drug, the excipient and the intended dosage form. Solubility measurements alone may not predict performance after digestion, while droplet size in a laboratory emulsion may not remain constant during storage. Developers must evaluate drug precipitation, lipid digestion, dissolution under biorelevant conditions, capsule compatibility, oxidation, microbial quality and scale-up behavior. The source and composition of lipids can also vary, making standardized characterization essential. Regulatory expectations therefore extend beyond demonstrating that an excipient is pharmaceutically acceptable; manufacturers must show that its quality remains consistent and that the finished product performs reliably.
By bringing these functions together, the article portrays lipid excipients as active tools in modern oral drug delivery rather than inert formulation aids. Their ability to solubilize challenging molecules, shape digestion, modify release, improve manufacturability and enhance acceptability could become increasingly valuable as pharmaceutical pipelines fill with hydrophobic and complex compounds. The authors’ discussion of Gattefossé’s portfolio illustrates how families of lipid materials can be matched to different formulation objectives, from self-emulsifying systems to controlled-release tablets and coated multiparticulates. The broader message is that the future of oral medicines may depend not only on discovering powerful active ingredients, but also on designing the lipid environment that allows those ingredients to work in the body.
Subject of Research: Multifunctional lipid excipients and their applications in oral pharmaceutical dosage forms.
Article Title: Multifunctional roles and innovative applications of lipid excipients in oral dosage forms: pharmaceutical considerations from Gattefossé’s lipid portfolio.
Article References: Yoon, K., Caisse, P., Ouyang, H. et al. “Multifunctional roles and innovative applications of lipid excipients in oral dosage forms: pharmaceutical considerations from Gattefossé’s lipid portfolio.” Journal of Pharmaceutical Investigation (2026). https://doi.org/10.1007/s40005-026-00821-6
Image Credits: AI Generated
DOI: https://doi.org/10.1007/s40005-026-00821-6
Keywords: Lipid excipients, oral drug delivery, poorly soluble drugs, self-emulsifying drug delivery systems, pharmaceutical formulation, controlled release, solubility enhancement, Gattefossé.
